We are live on
!
Find out more
FCMT
Founders Capital Management (Texas) Portfolio holdings
AUM
$231M
1-Year Est. Return
61.68%
This Fund
S&P 500
This Quarter
Est. Return
+8.26%
1 Year Est. Return
+61.68%
3 Year Est. Return
+118.08%
5 Year Est. Return
+149.3%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$7.32M
(+6.4%)
Cap. Flow
-$984K
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
40.5%
Holding
323
New
12
Increased
40
Reduced
40
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$909K |
| 2 |
Home Depot
HD
|
+$484K |
| 3 |
Lowe's Companies
LOW
|
+$479K |
| 4 |
iShares Biotechnology ETF
IBB
|
+$191K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$67.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$925K |
| 2 |
Kinder Morgan
KMI
|
+$774K |
| 3 |
Schwab International Equity ETF
SCHF
|
+$278K |
| 4 |
USCR
U S Concrete, Inc.
USCR
|
+$230K |
| 5 |
AT&T
T
|
+$166K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.93% |
| 2 | Energy | 12.25% |
| 3 | Healthcare | 10.83% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 10.12% |
Similar funds
CBOA
BIM
SM
MWM
MIM
SFP
TW
RWMG
Founders Capital Management (Texas)'s Q3 2018 Portfolio in Review
As of Q3 2018, Founders Capital Management (Texas) held 323 positions worth $121M, up 6.4% from $114M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Founders Capital Management (Texas)'s Q3 2018 filing shows 12 new, 40 increased, 40 reduced and 16 closed positions. Its largest new stake was McDermott International: 2,400 shares worth $44K. The largest sale was Novartis, an estimated $925K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Energy and Healthcare.
- Founders Capital Management (Texas)'s largest Q3 2018 buy was McDermott International: 2,400 shares worth $44K.
- Founders Capital Management (Texas) added most to Pfizer in Q3 2018, an estimated $909K increase.
- Founders Capital Management (Texas)'s biggest Q3 2018 reduction was Kinder Morgan, cutting an estimated $774K.
- Founders Capital Management (Texas) fully exited Novartis in Q3 2018, selling an estimated $925K.
- Founders Capital Management (Texas)'s ten largest holdings make up 41% of its $121M portfolio in Q3 2018.
- Founders Capital Management (Texas) opened 12 new positions and closed 16 in Q3 2018.
- Founders Capital Management (Texas)'s portfolio value rose 6.4% quarter-over-quarter to $121M.
Based on Founders Capital Management (Texas)'s 13F filing for Q3 2018, filed 5 Oct 2018.